MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ
34.76
+1.47
+4.42%
After Hours: 35.13 +0.37 +1.06% 18:27 01/27 EST
OPEN
33.19
PREV CLOSE
33.29
HIGH
35.13
LOW
33.15
VOLUME
171.31K
TURNOVER
0
52 WEEK HIGH
73.47
52 WEEK LOW
28.53
MARKET CAP
1.02B
P/E (TTM)
3.995
1D
5D
1M
3M
1Y
5Y
‘Multiple Expansion to Drive Stock Market Returns’: Raymond James Suggests 2 Stocks to Buy
TipRanks · 3d ago
BRIEF-Fulgent Adds Reggie Groves To Board Of Directors
Reuters · 01/03 22:00
Where Fulgent Genetics Stands With Analysts
Benzinga · 12/08/2022 15:03
Piper Sandler Downgrades Fulgent Genetics to Neutral, Lowers Price Target to $40
Benzinga · 12/08/2022 10:14
--Piper Sandler Downgrades Fulgent Genetics to Neutral From Overweight, Adjusts Price Target to $40 From $65
--Piper Sandler Downgrades Fulgent Genetics to Neutral From Overweight, Adjusts Price Target to $40 From $65
MT Newswires · 12/08/2022 08:06
5 Value Stocks In The Healthcare Sector
Benzinga · 12/05/2022 14:43
Owning 45% shares,institutional owners seem interested in Fulgent Genetics, Inc. (NASDAQ:FLGT),
If you want to know who really controls Fulgent Genetics, Inc. ( NASDAQ:FLGT ), then you'll have to look at the makeup...
Simply Wall St. · 12/02/2022 17:08
Fulgent Genetics's Return on Invested Capital Insights
Benzinga · 12/01/2022 14:50
More
About FLGT
Fulgent Genetics, Inc. is a technology company, which offers COVID-19 testing services, molecular diagnostic testing services and comprehensive genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the patient care quality. The Company develops a technology platform, which offers a test menu. It performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. It also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

Webull offers kinds of Fulgent Genetics Inc stock information, including NASDAQ:FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.